Quantcast
Home / News / Benchmarks: Fen-phen suit doesn’t survive MDL settlement

Benchmarks: Fen-phen suit doesn’t survive MDL settlement

The 3rd Circuit decided yesterday that a Pennsylvania woman’s fen-phen suit was barred under the explicit terms of a 1999 class settlement of diet drug claims by Wyeth Pharmaceuticals.


Lawyers USA has ceased publication. If you have purchased a research pass or still have additional time on your current Digital Subscription, you may access locked stories by logging in:







Scroll To Top